Division of Urology, Center for Reconstructive Urology and Men's Health, University of Utah, Salt Lake City, Utah.
Division of Epidemiology, University of Utah, Salt Lake City, Utah.
J Urol. 2014 Jan;191(1):159-63. doi: 10.1016/j.juro.2013.06.122. Epub 2013 Sep 16.
Prostate cancer treatment results in several sexually related side effects beyond the well studied erectile dysfunction. Climacturia (leakage of urine during orgasm) has been reported after prostatectomy but studies have been limited by multiple factors. In this study we examine the prevalence, causes and impact on orgasm function of climacturia after definitive treatment of prostate cancer with surgery or radiation.
A total of 906 anonymous surveys were sent to patients with prostate cancer treated with surgery and/or radiation. Respondents were asked about the presence of urinary leakage, climacturia and various elements related to sexual and orgasmic function. We estimated the prevalence of climacturia, evaluated the differences between those with and without climacturia, and assessed the impact of climacturia on orgasmic function.
Overall 412 surveys were returned and available for analysis, and of these respondents 75.2% were sexually active or experiencing orgasms. Climacturia was reported by 22.6% of these respondents, and by 28.3%, 5.2% and 28.6% of those treated with surgery, radiation, or both, respectively (p <0.001). The use of aides to obtain an erection (OR 2.24, 95% CI 1.08-4.93, p = 0.035) and the presence of urinary incontinence (OR 3.09, 95% CI 1.66-5.88, p <0.001) were also associated with climacturia in a multivariate logistic regression model. Climacturia had no significant impact on orgasmic function and satisfaction.
Climacturia is experienced by a substantial proportion of men after undergoing definitive treatment of prostate cancer. We found a complex relationship between stress urinary incontinence and climacturia, and noted that the presence of climacturia does not necessarily negatively impact sexual satisfaction.
前列腺癌的治疗除了众所周知的勃起功能障碍外,还会导致多种与性相关的副作用。射精后尿失禁(在性高潮时漏尿)虽已在前列腺切除术后报道过,但由于多种因素的影响,相关研究有限。在这项研究中,我们研究了手术或放疗治疗前列腺癌后,尿失禁的发生率、原因及其对性高潮功能的影响。
共向 906 名接受手术和/或放疗治疗的前列腺癌患者发送了 906 份匿名调查。调查内容包括尿失禁、射精后尿失禁及与性和性高潮功能相关的各种因素。我们评估了射精后尿失禁的发生率,比较了有和无射精后尿失禁患者之间的差异,并评估了射精后尿失禁对性高潮功能的影响。
共收到并分析了 412 份调查回复,其中 75.2%的受访者有性行为或性高潮。这些受访者中有 22.6%报告了射精后尿失禁,分别有 28.3%、5.2%和 28.6%的受访者接受了手术、放疗或两者联合治疗(p<0.001)。使用勃起辅助器具(OR 2.24,95%CI 1.08-4.93,p=0.035)和存在尿失禁(OR 3.09,95%CI 1.66-5.88,p<0.001)与多变量逻辑回归模型中的射精后尿失禁也有关。射精后尿失禁对性高潮功能和满意度没有显著影响。
相当一部分接受前列腺癌根治性治疗的男性会出现射精后尿失禁。我们发现压力性尿失禁与射精后尿失禁之间存在复杂的关系,并且注意到射精后尿失禁的存在不一定会对性满意度产生负面影响。